Versago Vascular Access said today it received $1.7 million in seed funding from Primo Medical Group’s network of investors to support its “reverse needle” subcutaneous access port. West Bridgewater, Mass.-based Versago, a spinoff of Primo Medical Group, has designed and developed a subcutaneous port to access the body’s bloodstream and anatomical cavities that collect serous […]
